Literature DB >> 17904128

Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection.

William M Buckett1, Ri-Cheng Chian, Nicola L Dean, Camille Sylvestre, Hananel E G Holzer, Seang Lin Tan.   

Abstract

OBJECTIVE: To compare rates of pregnancy loss after oocyte maturation in vitro (IVM), after IVF, and after intracytoplasmic sperm injection (ICSI).
DESIGN: Retrospective comparative study.
SETTING: University tertiary-care center for infertility. PATIENT(S): Women undergoing assisted reproductive technology in a single center. INTERVENTION(S): Oocyte maturation in vitro, IVF, or ICSI, as indicated. MAIN OUTCOME MEASURE(S): Biochemical pregnancy, clinical miscarriage, ectopic pregnancy, and late fetal loss. RESULT(S): There were 1,581 positive pregnancy tests (120 IVM, 849 IVF, and 612 ICSI). The biochemical pregnancy loss rate did not statistically significantly differ among the groups: 17.5% (21/120) after IVM, 17.0% (144/849) after IVF, and 18.0% (110/612) after ICSI. The clinical miscarriage rate after IVM was 25.3% (25/99), which was statistically significantly different compared with 15.7% (111/705) after IVF and 12.6% (63/502) after ICSI. However, the clinical miscarriage rates in women with polycystic ovary syndrome were statistically similar, at 24.5% (24/98) after IVM and 22.2% (18/81) after IVF. The ectopic pregnancy rates also were statistically similar: 1.0% (1/99) after IVM, 2.3% (16/705) after IVF, and 1.8% (9/502) after ICSI. The late fetal loss rates were similar as well: 1.0% (1/99) after IVM, 2.7% (19/705) after IVF, and 2.9% (14/502) after ICSI. There were no chromosomal abnormalities in the IVM group. CONCLUSION(S): There is a higher rate of clinical miscarriage after IVM when compared with IVF and ICSI. This appears to be related to polycystic ovary syndrome rather than to the IVM procedure.

Entities:  

Mesh:

Year:  2007        PMID: 17904128     DOI: 10.1016/j.fertnstert.2007.06.107

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  21 in total

1.  Methodology matters: IVF versus ICSI and embryonic gene expression.

Authors:  Phillip J Bridges; Myoungkun Jeoung; Heyoung Kim; Jung Ho Kim; Dong Ryul Lee; CheMyong Ko; Doris J Baker
Journal:  Reprod Biomed Online       Date:  2011-05-08       Impact factor: 3.828

2.  Aneuploidy in abortuses following IVF and ICSI.

Authors:  Vitaly A Kushnir; John L Frattarelli
Journal:  J Assist Reprod Genet       Date:  2009-02-18       Impact factor: 3.412

3.  Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve.

Authors:  Dan Nayot; Jin Tae Chung; Weon-Young Son; Assangla Ao; Mark Hughes; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2013-09-06       Impact factor: 3.412

4.  Association of late second trimester miscarriages with placental histology and autopsy findings.

Authors:  Hein Odendaal; Colleen Wright; Lucy Brink; Pawel Schubert; Elaine Geldenhuys; Coen Groenewald
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2019-10-22       Impact factor: 2.435

5.  Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome.

Authors:  Xiaoying Zheng; Lina Wang; Xiumei Zhen; Ying Lian; Ping Liu; Jie Qiao
Journal:  Reprod Biol Endocrinol       Date:  2012-05-24       Impact factor: 5.211

6.  The flip side of the coin: is the endometrium ready for IVM-derived embryo implantation?

Authors:  Ciler Celik-Ozenci
Journal:  J Assist Reprod Genet       Date:  2021-06-21       Impact factor: 3.357

Review 7.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

8.  Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles.

Authors:  Min Hye Choi; Sun Hee Lee; Hye Ok Kim; Sun Hwa Cha; Jin Young Kim; Kwang Moon Yang; In Ok Song; Mi Kyoung Koong; Inn Soo Kang; Chan Woo Park
Journal:  Clin Exp Reprod Med       Date:  2012-12-31

9.  In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.

Authors:  Charalampos S Siristatidis; Abha Maheshwari; Dennis Vaidakis; Siladitya Bhattacharya
Journal:  Cochrane Database Syst Rev       Date:  2018-11-15

Review 10.  Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation.

Authors:  Alex C Varghese; Stefan S du Plessis; Tommaso Falcone; Ashok Agarwal
Journal:  Reprod Biol Endocrinol       Date:  2008-10-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.